Ya‐Juan Zhu

Ya‐Juan Zhu

Auto-generated profile, based on publicly available information

Ya‐Juan Zhu

Department of Biotherapy and Cancer Center State Key Laboratory of Biotherapy West China Hospital Sichuan University Chengdu China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2023 in Clinical and Translational Medicine
Verified
Journal Article
Open access
YZYa‐Juan Zhu
Ya‐Juan Zhu
XLXiong Li
Xiong Li
TCTing‐Ting Chen
Ting‐Ting Chen
JWJia‐Xiang Wang
Jia‐Xiang Wang
YZYi‐Xin Zhou
Yi‐Xin Zhou
Ji-Yan LiuJi-Yan Liu
Ji-Yan Liu
Colorectal cancer (CRC) has become one of the most common tumours with high morbidity, mortality and distinctive evolution mechanism. The neoantigens arising from the somatic mutations have become considerable treatment targets in the management of CRC. As cancer‐specific aberrant peptides, neoantigens can trigger the robust host immune response and exert anti‐tumour effects while minimising the emergence of adverse events commonly associated with alternative therapeutic regimens. In this review, we summarised the mechanism, generation, identification and prognostic significance of neoantigens, as well as therapeutic strategies challenges of neoantigen‐based therapy in CRC. The evidence suggests that the establishment of personalised neoantigen‐based therapy holds great promise as an effective treatment approach for patients with CRC.